37018795|t|In vitro immunogenic profile of recombinant SARS-CoV2 S1-RBD peptide in murine macrophage and microglial cells.
37018795|a|BACKGROUND: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants can infect common mice inducing significant pathological lung lesions and inflammatory responses. This substantially mimics coronavirus disease 19 (COVID-19) infection and pathogenesis in humans. OBJECTIVES: To characterise the effects of recombinant SARS-CoV-2 S1 receptor-binding domain (RBD) peptide in murine macrophage and microglial cells' immune activation compared with classical PAMPs in vitro. METHODS: Murine RAW 264.7 macrophages and BV2 microglial cells were exposed to increasing concentrations of the RBD peptide (0.01, 0.05, and 0.1 microg/mL), Lipopolysaccharide (LPS) and Poly(I:C) and evaluated after two and 24 h for significant markers of macrophage activation. We determined the effects of RBD peptide on cell viability, cleaved caspase 3 expressions, and nuclear morphometry analysis. FINDINGS: In RAW cells, RBD peptide was cytotoxic, but not for BV2 cells. RAW cells presented increased arginase activity and IL-10 production; however, BV2 cells expressed iNOS and IL-6 after RBD peptide exposure. In addition, RAW cells increased cleaved-caspase-3, apoptosis, and mitotic catastrophe after RBD peptide stimulation but not BV2 cells. CONCLUSION: RBD peptide exposure has different effects depending on the cell line, exposure time, and concentration. This study brings new evidence about the immunogenic profile of RBD in macrophage and microglial cells, advancing the understanding of SARS-Cov2 immuno- and neuropathology.
37018795	44	53	SARS-CoV2	Species	2697049
37018795	54	56	S1	Gene	
37018795	72	78	murine	Species	10090
37018795	134	181	severe acute respiratory syndrome coronavirus 2	Species	2697049
37018795	183	193	SARS-CoV-2	Species	2697049
37018795	222	226	mice	Species	10090
37018795	261	273	lung lesions	Disease	MESH:D008171
37018795	278	290	inflammatory	Disease	MESH:D007249
37018795	328	371	coronavirus disease 19 (COVID-19) infection	Disease	MESH:D000086382
37018795	392	398	humans	Species	9606
37018795	455	465	SARS-CoV-2	Species	2697049
37018795	466	468	S1	Gene	
37018795	510	516	murine	Species	10090
37018795	617	623	Murine	Species	10090
37018795	624	633	RAW 264.7	CellLine	CVCL:0493
37018795	650	653	BV2	CellLine	CVCL:0182
37018795	765	783	Lipopolysaccharide	Chemical	MESH:D008070
37018795	785	788	LPS	Chemical	MESH:D008070
37018795	794	803	Poly(I:C)	Chemical	MESH:D011070
37018795	955	964	caspase 3	Gene	12367
37018795	1025	1028	RAW	CellLine	CVCL:F681
37018795	1052	1061	cytotoxic	Disease	MESH:D064420
37018795	1075	1078	BV2	CellLine	CVCL:0182
37018795	1086	1089	RAW	CellLine	CVCL:F681
37018795	1138	1143	IL-10	Gene	16153
37018795	1165	1168	BV2	CellLine	CVCL:0182
37018795	1185	1189	iNOS	Gene	18126
37018795	1194	1198	IL-6	Gene	16193
37018795	1240	1243	RAW	CellLine	CVCL:F681
37018795	1268	1277	caspase-3	Gene	12367
37018795	1352	1355	BV2	CellLine	CVCL:0182
37018795	1615	1624	SARS-Cov2	Disease	MESH:D045169

